Clinical Trial

Optimal Dosage of Melatonin for Preoperative Sedation in FESS

Study acronym: FESS
Completed Phase 4
View on ClinicalTrials.gov →
Summary
To determine the optimal dosage of Melatonin for preoperative sedation in patients undergoing FESS.
Trial Details
NCT Number NCT07550751
Lead Sponsor Aswan University Hospital
Conditions Clinical Trial
Enrollment 160 participants
Start Date 2024-08-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24